Women’s Health and Cannabis
Women are getting certified for pain due to endometriosis, pelvic floor pain, vulvodynia and interstitial cystitis. Although vaping, tinctures and capsules can provide some relief, utilizing vaginal suppositories can provide even more relief as they are able to target the issue right at the source. The fact that the vagina has a mucous membrane that can readily absorb medicine along with the female pelvic organs having a high density of cannabinoid receptors, make vaginal suppositories ideal and the potential to provide significant therapeutic benefit.
Vaginal suppositories are not an approved form of consumption in Pennsylvania; however, PA dispensaries do have the products needed to compound this form of consumption at home. THC and THC/CBD combination products that come in an oral syringe, as either a distillate or RSO form, is the main ingredient needed in making this form of consumption. The products themselves come already activated which makes the compounding process even easier. The transmucosal delivery has an onset of action occurring in about 15 to 20 minutes with effects lasting 4 to 8 hours.
Vaginal suppositories make for not only an effective form of treatment but also a very efficient way of introducing medicine into the body by having as much as 70% being absorbed. A pharmacist in the dispensary should be able to help assist in selecting the right product along with providing direction on how to compound the suppositories and provide information on calculating the desired dosing.
23 chronic insomnia patients treated with ZLT-101, Zelira’s proprietary and patented medicinal cannabis formulation, demonstrated statistically significant improvement in Insomnia Severity Index scores compared to placebo.
This research evaluates thousands of subjects who are current or past participants in the Pennsylvania Medical Marijuana Program who were asked to answer a variety of questions based on their first-hand experience.
As more of our patients are consuming cannabis on a regular basis, a common issue seems to be arising – TOLERENCE.